In FY23, Lupin invested 7.90% of its revenue in research and development.
During the quarter under review, the company reported an EBITDA of Rs 727 crore.
Priyavrat Bhartia will take over as the new MD from June 1, 2023.
Company's profitability was impacted due to a drastic surge in its expenses.
Intellectual Property Rights for Nidelgy will be retained by Philogen.
Last month, Cipla cracked a perpetual license agreement with Novartis.
In December 2022, Biocon’s net debt reached $1.9 billion.
Lupin now has 28 laboratories and 410 collection centers in India.
Company's stock price rises after its profit in the March quarter increases y-o-y by 31.3%.
Profit down due to decline in sales of its Covid drug.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
